ID29393A - Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah - Google Patents

Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah

Info

Publication number
ID29393A
ID29393A IDW00200101472A ID20011472A ID29393A ID 29393 A ID29393 A ID 29393A ID W00200101472 A IDW00200101472 A ID W00200101472A ID 20011472 A ID20011472 A ID 20011472A ID 29393 A ID29393 A ID 29393A
Authority
ID
Indonesia
Prior art keywords
oils
esensil
composition
cancer treatment
natural plant
Prior art date
Application number
IDW00200101472A
Other languages
English (en)
Indonesian (id)
Inventor
Steven M Bessette
Essam E Enan
Original Assignee
Ecosmart Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecosmart Technologies Inc filed Critical Ecosmart Technologies Inc
Publication of ID29393A publication Critical patent/ID29393A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW00200101472A 1998-12-07 1999-12-07 Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah ID29393A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11127198P 1998-12-07 1998-12-07

Publications (1)

Publication Number Publication Date
ID29393A true ID29393A (id) 2001-08-30

Family

ID=22337523

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101472A ID29393A (id) 1998-12-07 1999-12-07 Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah

Country Status (24)

Country Link
US (8) US20020182268A1 (de)
EP (3) EP1137427A1 (de)
JP (3) JP2002531511A (de)
KR (1) KR20010080692A (de)
CN (1) CN100448454C (de)
AR (3) AR020019A1 (de)
AT (1) ATE307601T1 (de)
AU (3) AU1841900A (de)
BR (1) BR9916879A (de)
CA (3) CA2353475A1 (de)
CZ (1) CZ20011979A3 (de)
DE (1) DE69928000T2 (de)
ES (1) ES2247858T3 (de)
HU (1) HUP0104674A3 (de)
ID (1) ID29393A (de)
IL (1) IL143488A0 (de)
MX (3) MXPA01005598A (de)
NO (1) NO20012774D0 (de)
NZ (1) NZ527850A (de)
PL (1) PL349028A1 (de)
RU (1) RU2252772C2 (de)
TR (1) TR200101481T2 (de)
WO (3) WO2000033857A1 (de)
ZA (1) ZA200104611B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033857A1 (en) * 1998-12-07 2000-06-15 Ecosmart Technologies, Inc. Cancer treatment composition and method using natural plant essential oils
DE10113513A1 (de) * 2001-03-20 2002-10-02 Medinnova Ges Med Innovationen Kombinationspräparat zur Prophylaxe und/oder Therapie von Nervenzell- und/oder Gliazellschäden durch ein neues Behandlungsverfahren
US7186735B2 (en) * 2002-08-07 2007-03-06 Sanofi-Aventis Deutschland Gmbh Acylated arylcycloalkylamines and their use as pharmaceuticals
EP2387882A3 (de) * 2002-08-12 2012-10-31 Lonza Inc. Zimtaldehyd enthaltende antimikrobielle Zusammensetzungen
CA2407755A1 (en) * 2002-10-11 2004-04-11 The Hospital For Sick Children Inhibition of vegf secretion
DE10259619A1 (de) * 2002-12-18 2004-07-08 Metagen Pharmaceuticals Gmbh Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung
MD2231C2 (ro) * 2003-03-05 2004-02-29 Ион КАЛМЫК Compozitie pentru tratamentul patologiilor oncologice
BRPI0410491A8 (pt) * 2003-04-24 2017-10-24 Univ Vanderbilt Composições e métodos para o controle de insetos
US7622269B2 (en) * 2004-03-19 2009-11-24 Tyratech, Inc. Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
US20060263403A1 (en) * 2003-04-24 2006-11-23 Essam Enan Compositions and methods for controlling insects involving the tyramine receptor
US7893072B2 (en) 2003-07-02 2011-02-22 Genentech, Inc. Trp-p8 active compounds and therapeutic treatment methods
DE10341933A1 (de) * 2003-09-11 2005-04-14 Lts Lohmann Therapie-Systeme Ag Medizinische Hautpflaster mit einem Gehalt an ätherischen Ölen zur Behandlung von Erkältungskrankheiten, sowie Verfahren für deren Herstellung
SE0401302D0 (sv) * 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Inhibition of erk-phosphorylation
WO2006120495A1 (fr) * 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
US20090035403A2 (en) * 2005-06-16 2009-02-05 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
CN100553628C (zh) * 2005-08-25 2009-10-28 中国人民解放军军事医学科学院放射与辐射医学研究所 2-溴-异香兰素在制备抗癌和/或辐射、化疗增敏药物中的应用
US20080145462A1 (en) * 2006-06-27 2008-06-19 Essam Enan Compositions and methods for treating parasitic infections
JP2009543870A (ja) * 2006-07-17 2009-12-10 タイラテック， インク． 昆虫防除のための組成物および方法
JP5587610B2 (ja) * 2007-01-16 2014-09-10 タイラテック， インク． 有害生物駆除組成物及び方法
JP2011021013A (ja) * 2009-06-19 2011-02-03 Ube Industries Ltd オキシル基を有する芳香族メチルアルコール化合物の製造方法
PL2480090T3 (pl) 2009-09-24 2014-04-30 Unilever Nv Środek dezynfekujący zawierający eugenol, terpineol oraz tymol
US8003393B1 (en) * 2010-02-09 2011-08-23 Panasonic Corporation Method for determining whether or not a mammal is affected with a lung cancer
WO2012006563A2 (en) 2010-07-08 2012-01-12 The Administrators Of The Tulane Educational Fund Novel daidzein analogs as treatment for cancer
FR2967055B1 (fr) * 2010-11-08 2012-12-21 Biochimie Appliquee Solabia Compositions cosmetiques a base d'esters de piperonyle et leur utilisation en sosmetique en tant qu'anti-vieillissement cutane et agent depigmentant
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
EP2714021A1 (de) * 2011-02-02 2014-04-09 Max Reynolds Zusammensetzung aus monoterpenoiden mit bakteriziden eigenschaften
US8952067B2 (en) * 2011-06-20 2015-02-10 Atheronova Operations, Inc. Subcutaneous fat reduction
EP2773315B1 (de) 2011-11-03 2015-07-08 Unilever N.V. Körperpflegezusammensetzung
KR101357395B1 (ko) 2012-08-06 2014-02-05 영남대학교 산학협력단 신규한 테트라졸로 하이드라존 유도체 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학 조성물
KR101688887B1 (ko) * 2014-01-03 2016-12-23 전북대학교산학협력단 신남알데히드 및 퀴논 메티드를 동시에 생성하는 혼성 항암 전구약물 및 이의 제조방법
WO2015102448A1 (ko) * 2014-01-03 2015-07-09 전북대학교 산학협력단 신남알데히드 및 퀴논 메티드를 동시에 생성하는 혼성 항암 전구약물 및 이의 제조방법
CA2939843C (en) * 2014-03-20 2023-08-29 Nestec S.A. Methods and compositions for using cinnamaldehyde and zinc for weight management
US20160106722A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
DE202015106125U1 (de) * 2015-10-23 2016-10-27 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Monoterpenhaltige Zusammensetzung zur Behandlung von Tumor- und/oder Krebserkrankungen
CN105294465A (zh) * 2015-12-08 2016-02-03 天津医科大学 一种抗乳腺癌转移作用的手性紫罗兰酮生物碱衍生物及医药用途
CN105559074B (zh) * 2016-02-03 2019-02-12 华南农业大学 一种茶叶挥发性精油在制备防癌保健品或抗癌药物中的应用
KR101798203B1 (ko) 2016-09-23 2017-11-15 전북대학교 산학협력단 산성 pH 및 에스테라아제에 의해 신남알데히드 및 퀴논메티드를 동시에 생성하는 혼성 항암 전구약물 및 이의 제조방법
CN112218620A (zh) 2018-04-06 2021-01-12 优卡健康有限公司 通过胍盐衍生物治疗癌症
CN109112106B (zh) * 2018-09-07 2022-01-04 广州长峰生物技术有限公司 人原代肝癌组织的体外模型的建立方法
WO2022069013A1 (fr) * 2020-10-04 2022-04-07 Omar Bencherguia Composition médicamenteuse pour le traitement et la prévention du covid-19 et autres infections et affections nouvelles applications de l'alpha-acetoxytoluène, l'alcool benzylique et les groupes benzyle dans la lutte contre la pandémie covid-19 et autres infections et affections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
JPS57106697A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same
US4751224A (en) * 1983-07-21 1988-06-14 Brown University Research Foundation Treatment of metastasis
FR2557452B1 (fr) * 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
DE3515253C1 (de) * 1985-04-27 1986-06-19 Werner 6780 Pirmasens Walter Verwendung von isopropanolischen Lösungen von Diphenyl als topisches Arzneimittel
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE3829200A1 (de) * 1988-08-29 1990-03-01 Kaempgen Dieter Dr Phil Wirkstoffe gegen die immunschwaeche-krankheit aids
JP2746453B2 (ja) * 1990-03-13 1998-05-06 鐘紡株式会社 活性酸素消去剤
EP0448029B1 (de) 1990-03-23 1995-12-20 Nippon Kayaku Kabushiki Kaisha Neue pharmazeutische Verwendungen von Forskolin-Derivaten
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
FR2683454B1 (fr) 1991-11-13 1995-06-09 Pf Medicament Composition pharmaceutique bactericide.
DK0663831T3 (da) * 1991-12-13 1995-07-26 Searle & Co Transdermal azidothymidin
ATE142523T1 (de) * 1992-04-29 1996-09-15 Nordica Spa Bremsvorrichtung an rollschuh
ATE275959T1 (de) * 1992-05-19 2004-10-15 Graham Edmund Kelly Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
US5602184A (en) * 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
US5387584A (en) * 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
JP3263481B2 (ja) 1993-05-19 2002-03-04 三洋電機株式会社 半導体装置および半導体装置の製造方法
FR2706771A1 (en) * 1993-06-21 1994-12-30 Pelletier Jacques Formula for the treatment of certain cancers.
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5626854A (en) 1994-03-17 1997-05-06 Kao Corporation Bath composition
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
HUP0002049A2 (hu) * 1997-03-04 2000-10-28 Wisconsin Alumni Research Foundation Tumornövekedés megakadályozására szolgáló eljárás izoprenoidok és sztatinok kombinációk alkalmazásával
AU7165798A (en) 1997-04-28 1998-11-24 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
DE69841434D1 (de) * 1997-07-18 2010-02-25 Novo Nordisk Healthcare Ag VERWENDUNG VON FVIIa ODER FVIIAi ZUR BEHANDLUNG VON ENDOTHELIALER FEHLFUNKTION BZW ZUR INHIBIERUNG DER ANGIOGENESE
EP1063960A1 (de) * 1998-03-20 2001-01-03 The Procter & Gamble Company Aroma freisetzendes mittel
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
EP1123106B1 (de) * 1998-10-23 2003-07-23 Dieter Ebert Zusammensetzung enthaltend eugenol und polyphenole, verwendung einer solchen zusammensetzung zur wundheilung
KR100312622B1 (ko) * 1998-11-03 2002-02-28 김송배 생약을주성분으로한안정화된항암제조성물및그제조방법
WO2000033857A1 (en) * 1998-12-07 2000-06-15 Ecosmart Technologies, Inc. Cancer treatment composition and method using natural plant essential oils
US6147107A (en) * 1998-12-20 2000-11-14 Virginia Commonwealth University Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells

Also Published As

Publication number Publication date
AR020019A1 (es) 2002-03-27
AR020021A1 (es) 2002-03-27
US20030108623A1 (en) 2003-06-12
IL143488A0 (en) 2002-04-21
WO2000033856A1 (en) 2000-06-15
CA2353516A1 (en) 2000-06-15
BR9916879A (pt) 2001-11-06
AR020020A1 (es) 2002-03-27
US7291650B2 (en) 2007-11-06
DE69928000T2 (de) 2006-06-08
CN100448454C (zh) 2009-01-07
ES2247858T3 (es) 2006-03-01
HUP0104674A3 (en) 2003-01-28
US7008649B2 (en) 2006-03-07
ZA200104611B (en) 2001-12-13
CN1329498A (zh) 2002-01-02
CA2353475A1 (en) 2000-06-15
HUP0104674A2 (en) 2002-06-29
JP2002531512A (ja) 2002-09-24
JP2002531511A (ja) 2002-09-24
NO20012774L (no) 2001-06-06
AU2167000A (en) 2000-06-26
MXPA01005598A (es) 2003-07-14
WO2000033857A9 (en) 2001-12-13
PL349028A1 (en) 2002-07-01
US6812258B2 (en) 2004-11-02
MXPA01005545A (es) 2003-07-14
AU1841900A (en) 2000-06-26
MXPA01005641A (es) 2003-07-14
TR200101481T2 (tr) 2001-09-21
US20030017218A1 (en) 2003-01-23
JP2002531513A (ja) 2002-09-24
WO2000033858A1 (en) 2000-06-15
US20030108622A1 (en) 2003-06-12
NZ527850A (en) 2004-07-30
US20080015249A1 (en) 2008-01-17
RU2252772C2 (ru) 2005-05-27
EP1137427A1 (de) 2001-10-04
EP1137426B1 (de) 2005-10-26
NO20012774D0 (no) 2001-06-06
US20030017215A1 (en) 2003-01-23
CA2353476A1 (en) 2000-06-15
DE69928000D1 (de) 2005-12-01
ATE307601T1 (de) 2005-11-15
AU2167100A (en) 2000-06-26
WO2000033857A1 (en) 2000-06-15
US20040146595A1 (en) 2004-07-29
KR20010080692A (ko) 2001-08-22
US20040156922A1 (en) 2004-08-12
EP1137425A1 (de) 2001-10-04
US20020182268A1 (en) 2002-12-05
CZ20011979A3 (cs) 2001-10-17
EP1137426A1 (de) 2001-10-04

Similar Documents

Publication Publication Date Title
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DE69703294T2 (de) Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
DE69910230D1 (de) Paclitaxel enthaltende arzneimittel
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
BR9811099A (pt) Inibidores de urocinase
ATE231872T1 (de) Thiazolopyrimidinderivate
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
SE9201628D0 (sv) Pharmaceutical composition
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
YU13301A (sh) Muskarinski agonisti i antagonisti
AU4830097A (en) Use of an extract of Cimicifuga
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
SE9802937D0 (sv) Novel compounds
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
BG105275A (en) Tan-1057 derivatives